The direct-to-consumer marketing strategy is clear: Increase the request for prescriptions written by educating consumers,
empowering them to act on behalf of their own health, and motivating them to do so. But one look at the typical customer lifecycle
curve shows that a customer's value neither begins nor ends with a product request. (See "Customer Lifecycle.") Rather, a
request marks the beginning of a relationship in which the customer's lifetime value for pharma is still uncertain. Thus,
companies must ask: "What happens after a customer requests a product? What role does pharma marketing play for that person?
What is the business case for building a relationship with the customer beyond traditional broadcast marketing and DTC advertising?"
Customer Life Cycle; The customer lifecycle begins with primary awareness, continues with conversion, and eventually extends
into the realm of compliance, customercare, and retention marketing.
This article describes the strategic role and economic potential-return on investment (ROI)-of marketing programs designed
to retain customers for a given product and its successors for as long as possible. It does so by highlighting one approach
to retention marketing-customer care programs.
Call them what you will-customer care, customer service, or loyalty programs. All have the same goal: to increase the customer's
value to the company over the customer lifecycle, thus maximizing the company's overall return. Although it typically takes
years to realize the ROI that retention marketing brings, several pharma companies have reduced their patient defection rate
by 10-20 percent annually. That can easily translate into $10-$20 million in revenue per year, even for a middle-market brand.
Shift in the Curve
The value of customer care is its ability to "shift the curve," a concept best explained as placing customer care in the context
of the traditional product lifecycle. (See "Rx Lifetime Run.") A product's typical life span includes research and development,
product launch, peak sales, and patent expiration. The marketing department's goals are to minimize the time it takes a product
to reach peak sales and to optimize that peak for the greatest period of time, taking into account the inevitable loss of
RX Lifetime Run; The opportunity for boosting a product's ROI through customer care and retention marketing lies in minimizing
the time to peak sales and optimizing that peak until patent expiration.
Although companies should address a customer care strategy early in the marketing plan's development, the primary benefit
for most programs comes when products approach peak sales. Today, most pharma companies define market potential by the traditional
product lifestyle standard, but there is a more efficient and timely way to maximize and sustain optimal profits. By targeting
marketing dollars to reach consumers with the highest potential lifetime value, companies can reduce the overall marketing
spend and optimize its allocation, investment, and efficiency.
Marketers must also factor in the individual customer lifecycle. In fact, the product lifecycle-and total profits curve-can
be interpreted as the sum of individual customer lifecycles over time. Hence, a marketing strategy that focuses on individuals
adds value to the product's lifecycle.
Customer care begins when the first patient receives a prescription or requests a product from a physician, and it continues
all the way through patent expiration-and, if possible, through a product conversion. Data from Cybercitizen Health (CCH)
show a critical unmet need for information and services from the moment patients receive a prescription through the moment
they stop therapy or switch products. (See "Patient Prompts," page 125.)
Patient Prompts; The leading incentive for consumers seeking pharma information online is the need to obtain supplementary
product-specific information after they receive a prescription.
Customer care can combine patient education, disease-management tools, prescription refill reminders, and coordinated outbound
retention marketing to targeted segments. Of course, companies must identify the target audience to whom they will offer such
services, when to offer them, and the optimal format and delivery method.
Customer care is not limited to compliance with a prescribed therapy; it also includes guiding the therapy's appropriate use
over the customer's lifetime, making behavioral modifications, lifestyle changes, and treatment an integral part of the process
to help consumers achieve optimal clinical outcomes.
Approximately half of pharma customers-those who need one or two cycles of treatment to remedy a temporary condition-can be
classified as acute. Investing in retention programs for that segment is unwarranted because the payoff is limited. It is
the other half of the market-those with chronic conditions-that delivers positive ROI for customer care and retention. If
properly organized, implemented, and maintained, customer-care programs directed toward chronic sufferers can result in optimized
customer lifetime value.
Enter the Internet
One of the most powerful new tools for customer care and retention marketing is the internet. Although most pharma companies
spend approximately 65-70 percent of their DTC budget on television advertising-for acquisition and branding-those investments
are unlikely to increase patient compliance or reduce customer "churn" over time. A comprehensive retention marketing and
customer-care program requires targeted communications and interactivity to achieve maximum impact and optimal ROI. The internet
is a relatively low-cost channel for interacting with targeted segments of the population in ways that television cannot.
People within various therapeutic segments want different things from a customer care program and will react in very different
ways to marketing programs and services.
Allergy sufferers may be interested in a program that sends only an e-mail communication when pollen counts are high, whereas
people with high cholesterol may want to receive a daily e-mail reminder to take their medication and hyperlinks to low-cholesterol